CNCK vs HIVE
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 19, 2026
CNCK
HIVE
Investment Advisor Scores
HIVE
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CNCK | HIVE | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 71.4286 | 62.8931 | HIVE |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 36.1% | 73.5% | HIVE |
| Earnings Growth | -68.9% | -99.9% | CNCK |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 60.9/100 | 65.8/100 | HIVE |
| Profit Margin | -0.3% | -98.5% | CNCK |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | STRONG BUY | HIVE |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CNCK
NeutralMixed signals - no dominant trend phase, RSI 46
HIVE
NeutralMixed signals - no dominant trend phase, RSI 52
Fundamentals Snapshot
| Metric | CNCK | HIVE |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -416.0 | -5.9 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.4% | 0.7% |
| Gross Margin | 0.0% | 0.4% |
| Operating Margin | 0.0% | -0.6% |
| EPS | -0.06 | -1.54 |
| Dividend Yield | — | — |